Search

Dexeus Mujer implements NIPT universally as a screening method to improve the sensitivity of chromosomal abnormality detection

Dexeus Mujer universaliza el TPNI como prueba de cribado para mejorar la sensibilidad y detección de las alteraciones cromosómicas

Dexeus Mujer implements NIPT universally as a screening method to improve the sensitivity of chromosomal abnormality detection

Dexeus Mujer has changed the way it screens for chromosomal abnormalities in the first trimester. All patients are now offered the option of a non-invasive test that analyses foetal DNA. This is one of the most accurate and reliable non-invasive prenatal screening tests (NIPT) on the market.

The screening programme is carried out around the 12th week of pregnancy and can detect the most common chromosomal abnormalities, such as trisomy 21 and trisomies 13 and 18, with a detection rate of between 98% and 99%.

For patients who wish to do so, other genetic abnormalities can be studied, such as abnormalities in the sex chromosomes, microdeletions/microduplications, or dominant monogenic variants, as it allows the study of CNVs from 3 Mb, it can detect more than 130 microdeletion/microduplication syndromes, including DiGeorge syndrome, which is the most common genetic disorder after Down syndrome (1/2000 births).

Finally, in addition to all the alterations mentioned above and the syndromes associated with microdeletion and microduplication, it also detects point mutations—up to 6,243 pathogenic variants—associated with more than 200 serious dominant monogenic pathologies and diseases, for which there is currently no other type of prenatal study.

More information

¿Cómo podemos ayudarte?

Te informamos que los datos de carácter personal que proporciones rellenando el presente formulario serán tratados por Fundación Dexeus Mujer como responsable de esta web. La finalidad de la recogida y tratamiento de estos datos es contactar contigo en referencia a tu solicitud y en caso de que expresamente nos autorices enviarte información sobre actividades, promociones y/o servicios y nuestro boletín informativo periódico. La legitimación se realiza a través del consentimiento del interesado. Podrás ejercer tus derechos de acceso, rectificación, limitación y suprimir los datos ante el delegado de protección de datos en dpd@dexeus.com así como el derecho a presentar una reclamación ante una autoridad de control. Puedes consultar la información adicional y detallada sobre Protección de Datos en nuestra política de privacidad.

How can we help you?

We inform you that the personal data that you provide by filling in this form will be treated by Dexeus Mujer Foundation as responsible for this website. The purpose of collecting and processing this data is to contact you regarding your request and in the event that you expressly authorize us to send you information on activities, promotions and / or services and our periodic newsletter. The legitimation is carried out through the consent of the interested party. You can exercise your rights of access, rectification, limitation and delete the data before the data protection officer at dpd@dexeus.com as well as the right to file a claim with a control authority. You can consult the additional and detailed information on Data Protection in our privacy policy.